Home / Health / Doctor Loses 31kg on Experimental Drug
Doctor Loses 31kg on Experimental Drug
13 Jul
Summary
- Physician lost 31kg on experimental GLP-1 drug retatrutide.
- Retatrutide targets GLP-1, GIP, and glucagon hormone receptors.
- Drug trial participants experienced significant weight loss and side effects.
A 39-year-old physician, Dr. Zubair Nabin K*, lost 31 kilograms during a two-year trial of the experimental weight-loss drug retatrutide. Previously struggling with obesity and emotional eating, he found the drug significantly curbed his appetite and transformed his health. Retatrutide, a new generation incretin mimetic, targets GLP-1, GIP, and glucagon receptors, showing greater weight loss in trials than existing medications.
While retatrutide offers remarkable weight reduction, potential side effects include diarrhoea and dysesthesia. Dr. Nabin experienced weekly bouts of diarrhoea and a tingling sensation from the drug. Some trial participants also faced negative social feedback about their changed appearance. Experts suggest focusing on health metrics over perception, as these powerful drugs may soon make bariatric surgeries largely obsolete.
